Future implications of polygenic risk scores for life insurance underwriting

Tiller, J., Otlowski, M. & Lacaze, P. Should Australia ban the use of genetic test results in life insurance? Front. Public Health 5, 330 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Joly, Y., Dupras, C., Pinkesz, M., Tovino, S. A. & Rothstein, M. A. Looking beyond GINA: policy approaches to address genetic discrimination. Annu. Rev. Genom. Hum. Genet. 21, 491–507 (2020).

Article  CAS  Google Scholar 

Otlowski, M., Taylor, S. & Bombard, Y. Genetic discrimination: international perspectives. Annu. Rev. Genom. Hum. Genet. 13, 433–454 (2012).

Article  CAS  Google Scholar 

Green, R. C., Lautenbach, D. & McGuire, A. L. GINA, genetic discrimination, and genomic medicine. N. Engl. J. Med. 372, 397–399 (2015).

Article  CAS  PubMed  Google Scholar 

Tiller, J. et al. Genetic discrimination by Australian insurance companies: a survey of consumer experiences. Eur. J. Hum. Genet. 28, 108–113 (2020).

Article  PubMed  Google Scholar 

Joly, Y., Ngueng Feze, I. & Simard, J. Genetic discrimination and life insurance: a systematic review of the evidence. BMC Med. 11, 25 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Wauters, A. & Van Hoyweghen, I. Global trends on fears and concerns of genetic discrimination: a systematic literature review. J. Hum. Genet. 61, 275–282 (2016).

Article  CAS  PubMed  Google Scholar 

Fraser, H. et al. Genetic discrimination by insurance companies in Aotearoa New Zealand: experiences and views of health professionals. N. Z. Med. J. 136, 32–52 (2023).

PubMed  Google Scholar 

Tiller, J. et al. Community concerns about genetic discrimination in life insurance persist in Australia: a survey of consumers offered genetic testing. Eur. J. Hum. Genet. (2023).

Keogh, L. A. et al. Choosing not to undergo predictive genetic testing for hereditary colorectal cancer syndromes: expanding our understanding of decliners and declining. J. Behav. Med. 40, 583–594 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Keogh, L. A. et al. Is uptake of genetic testing for colorectal cancer influenced by knowledge of insurance implications? Med. J. Aust. 191, 255 (2009).

Article  PubMed  Google Scholar 

Huizenga, C. R. et al. Evolving perspectives on genetic discrimination in health insurance among health care providers. Fam. Cancer 9, 253–260 (2010).

Article  PubMed  Google Scholar 

Prince, A. E. R., Uhlmann, W. R., Suter, S. M. & Scherer, A. M. Genetic testing and insurance implications: surveying the US general population about discrimination concerns and knowledge of the Genetic Information Nondiscrimination Act (GINA). Risk Manag Insur Rev. 24, 341–365 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Yanes, T. et al. Australian researcher’s perspectives on the Australian industry-led moratorium on genetic tests in life insurance. Am. J. Med. Genet. Part A. https://doi.org/10.1002/ajmg.a.63565.

Choi, S. W., Mak, T. S.-H. & O’Reilly, P. F. Tutorial: a guide to performing polygenic risk score analyses. Nat. Protoc. 15, 2759–2772 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wand, H. et al. Improving reporting standards for polygenic scores in risk prediction studies. Nature 591, 211–219 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yanes, T., McInerney-Leo, A., Law, M. & Cummings, S. The emerging field of polygenic risk scores and perspective for use in clinical care. Hum. Mol. Genet. 29, R165–R176 (2020).

Article  CAS  PubMed  Google Scholar 

Lewis, A. C. F. & Green, R. C. Polygenic risk scores in the clinic: new perspectives needed on familiar ethical issues. Genome Med. 13, 14 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Lambert, S. A., Abraham, G. & Inouye, M. Towards clinical utility of polygenic risk scores. Hum. Mol. Genet. 28, R133–r42 (2019).

Article  CAS  PubMed  Google Scholar 

Adeyemo, A. et al. Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps. Nat. Med. 27, 1876–1884 (2021).

Article  Google Scholar 

Yanes, T., Young, M.-A., Meiser, B. & James, P. A. Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field. Breast Cancer Res. 22, 21 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Vassy, J. L. et al. Perceived benefits and barriers to implementing precision preventive care: results of a national physician survey. Eur. J. Hum. Genet. 31, 1309–1316 (2023).

Article  PubMed  Google Scholar 

Linnér, R. K. & Koellinger, P. D. Genetic risk scores in life insurance underwriting. J. Health Econ. 81, 102556 (2021).

Article  Google Scholar 

Venning, B., Saya, S., De Abreu Lourenco, R., Street, D. J. & Emery, J. D. Preferences for a polygenic test to estimate cancer risk in a general Australian population. Genet. Med. 24, 2144–2154 (2022).

Article  CAS  PubMed  Google Scholar 

HM Government and Association of British Insurers. Code on Genetics and Insurance London: HM Government; [cited HM Government. Available from: https://www.abi.org.uk/globalassets/files/publications/public/genetics/code-on-genetic-testing-and-insurance-final.pdf. (2018).

Financial Services Council. FSC Standard No. 11: Moratorium on Genetic Tests in Life Insurance 2019 [updated 21 June Available from: https://www.fsc.org.au/resources-category/standard/1779-standard-11-moratorium-on-genetic-tests-in-life-insurance/file. (2019).

Genetic Non-Discrimination Act, SC 2017, c.3. [Available from: https://laws-lois.justice.gc.ca/eng/acts/G-2.5/index.html. (2017).

Genetic Information Nondiscrimination Act of 2008, Pub L 110-233, 122 Stat 881 [Available from: https://www.eeoc.gov/statutes/genetic-information-nondiscrimination-act-2008 (2008).

Kim, H. et al. Genetic discrimination: introducing the Asian perspective to the debate. npj Genom. Med. 6, 54 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Treasury Department. Press Confernce: Release of consultation paper on treatment of genetic testing information for life insurance [Available from: https://ministers.treasury.gov.au/ministers/stephen-jones-2022/transcripts/press-conference-mural-hall-parliament-house-canberra (2024).

Use of genetic testing results in life insurance underwriting. In: Department T, editor. Canberra (2023).

Wand, H. et al. Clinical genetic counseling and translation considerations for polygenic scores in personalized risk assessments: a practice resource from the national society of genetic counselors. J. Genet. Counsel. 32, 558–575 (2023).

Article  Google Scholar 

Martin, A. R., Daly, M. J., Robinson, E. B., Hyman, S. E. & Neale, B. M. Predicting polygenic risk of psychiatric disorders. Biol. Psychiatry 86, 97–109 (2019).

Article  PubMed  Google Scholar 

Kumuthini, J. et al. The clinical utility of polygenic risk scores in genomic medicine practices: a systematic review. Hum. Genet. 141, 1697–1704 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Peck, L., Borle, K., Folkersen, L. & Austin, J. Why do people seek out polygenic risk scores for complex disorders, and how do they understand and react to results? Eur. J. Hum. Genet. (2021).

Gray, S. W. et al. Personal genomic testing for cancer risk: results from the impact of personal genomics study. J. Clin. Oncol. 35, 636–644 (2017).

Article  PubMed  Google Scholar 

Widén, E. et al. How communicating polygenic and clinical risk for atherosclerotic cardiovascular disease impacts health behavior: an observational follow-up study. Circ. Genom. Precis. Med. Circgen121003459 (2022).

Timms, M. Polygenic risk scores and what it means for the genetic testing moratorium [Available from: https://www.actuaries.digital/2022/07/08/polygenic-risk-scores-and-what-it-means-for-the-genetic-testing-moratorium/(2022).

Vukcevic, D. & Chen, J. Advances in genetics and their impact on life insurance. Actuaries Institute [Available from https://www.actuaries.asn.au/Library/Events/FSF/2018/VukcevicChenPaper.pdf (2018).

Ganna, A. et al. Genetic determinants of mortality. Can findings from genome-wide association studies explain variation in human mortality? Hum. Genet. 132, 553–561 (2013).

Article  PubMed  Google Scholar 

Meisner, A. et al. Combined utility of 25 disease and risk factor polygenic risk scores for stratifying risk of all-cause mortality. Am. J. Hum. Genet. 107, 418–431 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Joly, Y. et al. Establishing the International genetic discrimination observatory. Nat. Genet. 52, 466–468 (2020).

Article  CAS  PubMed  Google Scholar 

Nguengang Wakap, S. et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur. J. Hum. Genet. 28, 165–173 (2020).

Article  PubMed  Google Scholar 

National Comprehensive Cancer Network. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic [Version 1.2023:[Available from: https://www.nccn.org/guidelines/guidelines-detail?category=2&id=1503 ‘15.11.22’[15.11.22]. (2022).

eviQ Cancer Treatments. Genetic Testing for Heritable Mutations in the BRCA1 and BRCA2 Genes [Available from: https://www.eviq.org.au/cancer-genetics/adult/genetic-testing-for-heritable-pathogenic-variants/620-brca1-and-brca2-genetic-testing (2021).

National Institute for Health and Care Excellence. Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer. (2019).

Hüls, A. et al. Polygenic risk for obesity and its interaction with lifestyle and sociodemographic factors in European children and adolescents. Int. J. Obes. 45, 1321–1330 (2021).

Article  Google Scholar 

Newson, A. J., Tiller, J., Keogh, L. A., Otlowski, M. & Lacaze, P. Genetics and Insurance in Australia: concerns around a self-regulated industry. Public Health Genom. 20, 247–256 (2017).

Article  Google Scholar 

Young, M. A. et al. Human genetics society of Australasia position statement: use of polygenic scores in clinical practice and population health. Twin Res. Hum. Genet 26, 40–48 (2023).

Article  PubMed  Google Scholar 

O’Sullivan, J. W. et al. Polygenic risk scores for cardiovascular disease: a scientific statement from the American heart association. Circulation 146, e93–e118 (2022).

Article  PubMed  PubMed Central 

留言 (0)

沒有登入
gif